Insulet Corporation to Present at Upcoming Investor Conference
November 13 2017 - 8:00AM
Business Wire
Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in
tubeless insulin pump technology with its Omnipod® Insulin
Management System, today announced that management will present at
the Jefferies 2017 London Healthcare Conference on November 15,
2017, at 9:20am local London time.
This press release features multimedia. View
the full release here:
http://www.businesswire.com/news/home/20171113005071/en/
To listen to a live audio webcast of the presentation, please
visit http://investors.insulet.com/. A replay of the webcast
will also be available following the event.
About Insulet Corporation:
Insulet Corporation is an innovative medical device company
dedicated to making the lives of people with diabetes easier.
Insulet seeks to expand the use of insulin pump therapy with its
Omnipod Insulin Management System among people with
insulin-dependent diabetes. The Omnipod System is a revolutionary
and easy-to-use tubeless insulin pump that provides up to three
days of non-stop insulin delivery, without the need to see or
handle a needle. Insulet's Delivery Systems business partners with
global pharmaceutical and biotechnology companies to adapt the
Omnipod technology platform for the delivery of subcutaneous drugs
across multiple therapeutic areas. Founded in 2000, Insulet
Corporation is based in Billerica, Massachusetts. For more
information, please visit: http://www.myomnipod.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171113005071/en/
Investor Relations and Media Contact:Insulet
CorporationDeborah R. Gordon, 978-600-7717Vice President, Investor
Relations and Corporate Communicationsdgordon@insulet.com
Insulet (NASDAQ:PODD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Insulet (NASDAQ:PODD)
Historical Stock Chart
From Sep 2023 to Sep 2024